These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7309234)

  • 1. Protein A effect on alternative pathway complement activation and opsonization of Staphylococcus aureus.
    Spika JS; Verbrugh HA; Verhoef J
    Infect Immun; 1981 Nov; 34(2):455-60. PubMed ID: 7309234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
    Tofte RW; Peterson PK; Schmeling D; Bracke J; Kim Y; Quie PG
    Infect Immun; 1980 Mar; 27(3):784-92. PubMed ID: 6103873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Verhoef J
    Immunology; 1979 Jul; 37(3):615-21. PubMed ID: 500119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
    Verhoef J; Peterson P; Kim Y; Sabath LD; Quie PG
    Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers.
    Wilkinson BJ; Peterson PK; Quie PG
    Infect Immun; 1979 Feb; 23(2):502-8. PubMed ID: 422250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The key role of peptidoglycan in the opsonization of Staphylococcus aureus.
    Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Douglas SD; Quie PG; Verhoef J
    J Clin Invest; 1978 Mar; 61(3):597-609. PubMed ID: 641141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes.
    Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Quie PG
    Infect Immun; 1978 Mar; 19(3):943-9. PubMed ID: 640738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of serum concentration on opsonization by the classical and alternative complement pathways.
    Tofte RW; Peterson PK; Kim Y; Quie PG
    Infect Immun; 1980 Feb; 27(2):693-6. PubMed ID: 6991425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.
    Peterson PK; Kim Y; Wilkinson BJ; Schmeling D; Michael AF; Quie PG
    Infect Immun; 1978 Jun; 20(3):770-5. PubMed ID: 352958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
    Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
    J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-based dialysis fluids inhibit innate defense against Staphylococcus aureus.
    Kumar PS; Mauriello CT; Hair PS; Rister NS; Lawrence C; Raafat RH; Cunnion KM
    Mol Immunol; 2015 Oct; 67(2 Pt B):575-83. PubMed ID: 26256795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains.
    Verbrugh HA; van Dijk WC; van Erne ME; Peters R; Peterson PK; Verhoef J
    Infect Immun; 1979 Dec; 26(3):808-14. PubMed ID: 393633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.
    Van Dijk WC; Verbrugh HA; van der Tol ME; Peters R; Verhoef J
    Infect Immun; 1979 Aug; 25(2):603-9. PubMed ID: 385502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocytosis and destruction of Staphylococcus aureus.
    Verbrugh HA
    Vet Q; 1981 Apr; 3(2):91-7. PubMed ID: 7245175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
    Matthay KK; Mentzer WC; Wara DW; Preisler HK; Lameris NB; Ammann AJ
    Infect Immun; 1981 Jan; 31(1):228-35. PubMed ID: 7216447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mannose-binding lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding.
    Brouwer N; Dolman KM; van Houdt M; Sta M; Roos D; Kuijpers TW
    J Immunol; 2008 Mar; 180(6):4124-32. PubMed ID: 18322223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of protein A on staphylococcal opsonization.
    Peterson PK; Verhoef J; Sabath LD; Quie PG
    Infect Immun; 1977 Mar; 15(3):760-4. PubMed ID: 870431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in the degree of opsonization and phagocytosis of strains of Staphylococcus aureus isolated from patients with disseminated intravascular coagulation.
    Tuazon CU; Sheagren JN; Quie PG
    J Lab Clin Med; 1981 Dec; 98(6):949-55. PubMed ID: 7310231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.